APPRISE Virtual Biobank Revolutionizes Infectious Disease Research in Australia with a National Collaborative Platform

A virtual biobank launched by APPRISE to accelerate pandemic research, providing easier access to critical human samples for outbreak studies.

New Virtual Biobank Platform Launches to Enhance Outbreak Response and Improved Human Samples Access
Advertisement img

In a significant stride for pandemic research, Australia has unveiled a ‘virtual’ bank of human samples, a novel initiative designed to escalate the response to outbreaks through improved access to critical specimens.

This cutting-edge virtual biobank, developed during the COVID-19 pandemic by the Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE) and funded by the National Health and Medical Research Council, represents a pioneering approach in infectious disease research.

Dr. Miranda Smith, associated with the University of Melbourne and APPRISE, emphasized the virtual biobank’s role in creating a more nationally unified biobanking strategy for infectious diseases in Australia.

Featured Partners

She highlighted the challenges faced during the COVID-19 pandemic in sharing research samples and underscored the necessity for more efficient methods to distribute these critical specimens across Australia for urgent research.

This system substantially streamlines the process of identifying and accessing samples, crucial for rapid response during outbreaks. Biogrid Australia has developed this virtual biobank’s technical architecture, which currently houses over 58,000 samples from six collections, with more collections being prepared for inclusion.

This platform aims to make these invaluable human samples more accessible for research, thereby enhancing the use of existing resources and establishing a sustainable foundation for addressing current and future infectious disease challenges.

Read more here.